Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$57.6M |
| 2 |
Intellia Therapeutics
NTLA
|
+$54.8M |
| 3 |
Stratasys
SSYS
|
+$44.4M |
| 4 |
Baidu
BIDU
|
+$42.2M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
+$34.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$31.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$14.8M |
| 3 |
FMI
Foundation Medicine, Inc.
FMI
|
+$12.6M |
| 4 |
Trip.com Group
TCOM
|
+$6.96M |
| 5 |
LendingTree
TREE
|
+$5.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.29% |
| 2 | Healthcare | 23.12% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Communication Services | 13.72% |
| 5 | Industrials | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Adobe
ADBE
$109B
| $7.72M | 0.38% |
35,752
+16,839
| +89% | +$3.42M |
|
52
ServiceNow
NOW
$133B
| $7.04M | 0.35% |
212,590
+100,115
| +89% | +$3.09M |
|
|
FMI
53
DELISTED
Foundation Medicine, Inc.
FMI
| $6.88M | 0.34% |
87,434
-171,251
| -66% | -$12.6M |
|
54
Microsoft
MSFT
$3.59T
| $6.47M | 0.32% |
70,898
+53,370
| +304% | +$4.88M |
|
55
Box
BOX
$4.56B
| $4.96M | 0.25% |
241,263
+109,452
| +83% | +$2.36M |
|
56
Align Technology
ALGN
$11.5B
| $4.54M | 0.23% |
18,084
+2,012
| +13% | +$517K |
|
|
MZOR
57
DELISTED
Mazor Robotics Ltd.
MZOR
| $4.23M | 0.21% |
68,940
+24,905
| +57% | +$1.56M |
|
|
CELG
58
DELISTED
Celgene Corp
CELG
| $4.2M | 0.21% |
47,022
+37,327
| +385% | +$3.58M |
|
59
Trimble
TRMB
$14B
| $4.09M | 0.2% |
114,020
+29,976
| +36% | +$1.21M |
|
60
Biogen
BIIB
$32B
| $3.85M | 0.19% |
14,080
+7,501
| +114% | +$2.33M |
|
61
Teladoc Health
TDOC
$1.16B
| $3.67M | 0.18% |
90,972
+59,651
| +190% | +$2.25M |
|
|
ANSS
62
DELISTED
Ansys
ANSS
| $3.57M | 0.18% |
22,812
+3,877
| +20% | +$620K |
|
63
General Motors
GM
$77.2B
| $3.39M | 0.17% |
93,407
-23,354
| -20% | -$947K |
|
64
CRISPR Therapeutics
CRSP
$5.75B
| $3.32M | 0.16% |
72,534
+41,146
| +131% | +$1.7M |
|
65
3D Systems Corp
DDD
$530M
| $3.23M | 0.16% |
278,302
+56,006
| +25% | +$598K |
|
66
Inovio Pharmaceuticals
INO
$122M
| $3.13M | 0.16% |
55,368
+31,512
| +132% | +$1.71M |
|
|
MGT
67
DELISTED
MGT CAPITAL INVESTMENTS INC COM NEW (DE)
MGT
| $3.09M | 0.15% |
+2,401,343
| New | +$3.09M |
|
|
CLLS
68
Cellectis
CLLS
$342M
| $2.76M | 0.14% |
87,597
+43,215
| +97% | +$1.37M |
|
69
Gilead Sciences
GILD
$181B
| $2.75M | 0.14% |
36,475
+12,801
| +54% | +$1.02M |
|
70
HP
HPQ
$27.2B
| $2.72M | 0.14% |
124,195
+6,241
| +5% | +$141K |
|
71
Incyte
INCY
$25.9B
| $2.52M | 0.13% |
30,303
+19,299
| +175% | +$1.74M |
|
72
Elbit Systems
ESLT
$34.7B
| $2.19M | 0.11% |
18,054
+5,900
| +49% | +$818K |
|
|
JNCE
73
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.08M | 0.1% |
93,143
+39,967
| +75% | +$887K |
|
74
Deere & Co
DE
$175B
| $2.05M | 0.1% |
13,203
-5,584
| -30% | -$906K |
|
75
Twilio
TWLO
$34.6B
| $2.05M | 0.1% |
53,688
-102,932
| -66% | -$3.26M |
|
Similar funds
Cathie Wood's Q1 2018 Portfolio in Review
As of Q1 2018, Cathie Wood held 213 positions worth $2.01B, up 60% from $1.26B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Cathie Wood deployed $731M of net new capital in Q1 2018, opening 13 new positions and adding to 155 existing holdings. Its largest new stake was TSMC: 217,209 shares worth $9.51M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $14.8M trimmed.
- Cathie Wood's largest Q1 2018 buy was TSMC: 217,209 shares worth $9.51M.
- Cathie Wood added most to Tesla in Q1 2018, an estimated $57.6M increase.
- Cathie Wood's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $14.8M.
- Cathie Wood fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $31.2M.
- Cathie Wood's ten largest holdings make up 37% of its $2.01B portfolio in Q1 2018.
- Cathie Wood opened 13 new positions and closed 14 in Q1 2018.
- Cathie Wood's portfolio value rose 60% quarter-over-quarter to $2.01B.
Based on ARK Investment Management's 13F filing for Q1 2018, filed 14 May 2018.